You are currently viewing a new version of our website. To view the old version click .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 27, Issue 6

December 2020 - 23 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (23)

  • Article
  • Open Access
8 Citations
1,546 Views
7 Pages

A Population-Based Study of Pulmonary Monitoring and Toxicity for Patients with Testicular Cancer Treated with Bleomycin

  • M.J. Raphael,
  • M.D. Lougheed,
  • X. Wei,
  • S. Karim,
  • A.G. Robinson,
  • P.L. Bedard and
  • C.M. Booth

1 December 2020

Background:Bleomycin is commonly used to treat advanced testicular cancer and can be associated with severe pulmonary toxicity. The primary objective of the present study was to describe the use of pulmonary function tests (PFTs) and chest imaging be...

  • Article
  • Open Access
8 Citations
2,431 Views
6 Pages

A Systematic Review and Network Meta-Analysis of Second-Line Therapy in Hepatocellular Carcinoma

  • S. Delos Santos,
  • S. Udayakumar,
  • A. Nguyen,
  • Y.J. Ko,
  • S. Berry,
  • M. Doherty and
  • K.K.W. Chan

1 December 2020

Background: In patients with advanced hepatocellular carcinoma (HCC) following sorafenib failure, it is unclear which treatment is most efficacious, as treatments in the second-line setting have not been directly compared and no standard therapy exis...

  • Article
  • Open Access
14 Citations
1,598 Views
6 Pages

The Cost of Failed First-Line Cancer Treatment Related to Continued Smoking in Canada

  • N. Iragorri,
  • B. Essue,
  • C. Timmings,
  • D. Keen,
  • H. Bryant and
  • G.W. Warren

1 December 2020

Background: Smoking by cancer patients and survivors causes adverse cancer treatment outcomes, but little information is available about how smoking can affect cancer treatment costs. Methods: We developed a model to estimate attributable cancer trea...

  • Article
  • Open Access
10 Citations
1,669 Views
8 Pages

Perspectives of Hematology Oncology Clinicians about Integrating Palliative Care in Oncology

  • R. Booker,
  • S. Dunn,
  • M.A. Earp,
  • A. Sinnarajah,
  • P.D. Biondo and
  • J.E. Simon

1 December 2020

Patients with hematologic malignancies receive palliative care (PC) less frequently and later than patients with solid tumours. We compared survey responses of hematology oncology clinicians with other oncology clinicians to better understand their c...

  • Article
  • Open Access
30 Citations
3,079 Views
9 Pages

Consensus Recommendations for Optimizing Biomarker Testing to Identify and Treat Advanced EGFR-Mutated Non-Small-Cell Lung Cancer

  • P.K. Cheema,
  • M. Gomes,
  • S. Banerji,
  • P. Joubert,
  • N.B. Leighl,
  • B. Melosky,
  • B.S. Sheffield,
  • T. Stockley and
  • D.N. Ionescu

1 December 2020

The advent of personalized therapy for non-small-cell lung carcinoma (nsclc) has improved patient outcomes. Selection of appropriate targeted therapy for patients with nsclc now involves testing for multiple biomarkers, including EGFR. EGFR mutation...

  • Case Report
  • Open Access
17 Citations
2,479 Views
6 Pages

1 December 2020

Introduction: The abscopal effect is a rarely observed outcome of radiotherapy wherein there is a reduction in metastatic disease burden outside of the targeted treatment area. Likely due to an in situ vaccine effect of radiotherapy, the abscopal eff...

  • Article
  • Open Access
24 Citations
3,719 Views
5 Pages

1 December 2020

Lymphedema is a chronic inflammatory condition that results from damage to the lymphatic system. Lymphedema is classified as either primary or secondary, the former being caused by a malformation of lymph vessels or nodes, and the latter resulting fr...

  • Article
  • Open Access
11 Citations
1,570 Views
10 Pages

1 December 2020

Background: Gastric adenosquamous carcinoma (GASC) is a rare entity with distinctive characteristics that are not fully understood. In the present study, we evaluated the characteristics of this rare disease. Methods: The U.S. Surveillance, Epidemiol...

  • Article
  • Open Access
13 Citations
1,775 Views
10 Pages

1 December 2020

Background: Treatment of hepatic metastases from neuroendocrine tumours improves survival and symptom relief. Hepatic arterial embolotherapy techniques include transarterial chemoembolization (TACE) and bland embolization (TAE). The relative efficacy...

  • Article
  • Open Access
2 Citations
1,420 Views
5 Pages

Presenting Stage and Risk Group in Men Dying of Prostate Cancer

  • S. Parimi,
  • S. Bondy,
  • M. Aparicio,
  • K. Sunderland,
  • J. Cho,
  • F. Bachand,
  • K. Nguyen Chi,
  • T. Pickles and
  • S. Tyldesley

1 December 2020

Introduction: Prostate cancer remains the 3rd leading cause of cancer-related mortality in Canadian men, and yet screening for prostate cancer continues to be controversial because the majority of men diagnosed with prostate cancer do not die of the...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729